Evaxion Biotech A/S - ADR EVAX

NAS: EVAX | ISIN: US29970R1059 15/09/2025

2,920 USD (-0,85%)

(-0,85%) 15/09/2025

Grafiek Evaxion Biotech A/S - ADR

Grafiek Evaxion Biotech A/S - ADR

1 dag1d -0,85%
1 week1w 3,55%
1 maand1m -9,32%
3 maanden3m 41,06%
6 maanden6m 56,15%
1 jaar1j -3,63%
5 jaar5j -70,48%

Evaxion Biotech A/S - ADR in het nieuws

Toon enkel gratis nieuws

27 augustus 2025 · Evaxion to present at several conferences during the second half of 2025 · Persbericht

14 augustus 2025 · Evaxion announces business update and second quarter 2025 financial results · Persbericht

11 augustus 2025 · Evaxion to announce business update and second quarter 2025 financial results on August 14, 2025 · Persbericht

25 juli 2025 · Evaxion to present two-year clinical efficacy data from phase 2 trial with AI-designed personalized cancer vaccine EVX-01 at the ESMO Congress 2025 · Persbericht

11 juli 2025 · Evaxion finalizes agreement with EIB to convert debt into equity · Persbericht

1 juli 2025 · Evaxion announces changes to Executive Management to optimize the value of proprietary AI-Immunology™ platform and portfolio · Persbericht

25 juni 2025 · Evaxion expands R&D pipeline with new vaccine program targeting Group A Streptococcus · Persbericht

3 juni 2025 · Evaxion receives grant funding to design new polio vaccine · Persbericht

27 mei 2025 · Evaxion announces business update and first quarter 2025 financial results · Persbericht

23 mei 2025 · Evaxion to announce business update and first quarter 2025 financial results on May 27, 2025 · Persbericht

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe